Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
02/1995
02/01/1995EP0636372A1 Antiviral, antitumor, antimetastatic, immune system enhancing 7-thia-guanosine derivatives
02/01/1995EP0636180A1 T CELL EPITOPES OF THE MAJOR ALLERGENS FROM $i(AMBROSIA ARTEMISIIFOLIA)
02/01/1995EP0636177A1 ISOLATION, CHARACTERIZATION, AND USE OF THE HUMAN $g(b) SUBUNIT OF THE HIGH AFFINITY RECEPTOR FOR IMMUNOGLOBULIN E
02/01/1995EP0636176A1 Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily
02/01/1995EP0636127A1 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity
02/01/1995EP0636119A1 Phenyl substituted cycloalkyl hydroxyurea derivatives which inhibit lipoxygenase
02/01/1995EP0636026A1 Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor
02/01/1995EP0636025A1 Compounds useful for treating allergic or inflammatory diseases
02/01/1995EP0535150B1 Human macrophage inflammatory protein 2-beta
01/1995
01/31/1995US5386031 Process for the synthesis of 2-amino-3,5-dihydro-7-substituted-4H-pyrrolo[3,]pyrimidin-4-ones
01/31/1995US5386011 Hexapeptide anaphylatoxin-receptor ligands
01/31/1995US5385947 Octahydrophenanthrene derivatives
01/31/1995US5385918 Aminomethylene-peptides as immunosuppressants
01/31/1995US5385909 Heterocyclic esters of rapamycin
01/31/1995US5385908 Immunosuppressants, antiinflammatory agents
01/31/1995US5385907 Ointments containing FK-506 or derivatives thereof
01/31/1995US5385904 Therapy for immunology diseases
01/31/1995US5385832 Cultivating cells in growth medium, separating, extracting with methanol and chloroform, acid-washing
01/31/1995US5385734 Horseradish preparation for the treatment of nasal and sinus dysfunction
01/31/1995CA1334200C Leukotriene antagonists
01/31/1995CA1334197C Hetera-aliphatic carboxamides
01/30/1995CA2126523A1 Jak kinases and regulation of cytokine signal transduction
01/26/1995WO1995002686A1 Redirection of cellular immunity by receptor chimeras
01/26/1995WO1995002600A1 Antiallergic imidazoazepines
01/26/1995WO1995002595A1 Benzyloxyquinuclidines as substance p antagonists
01/26/1995WO1995002591A1 Tri-substituted imidazoles having multiple therapeutic properties
01/26/1995WO1995002583A1 Process for making hiv protease inhibitors
01/26/1995WO1995002577A1 Novel vitamin d analogues
01/26/1995WO1995002398A1 Pharmaceutical composition for immunomodulating and adjuvant treatment
01/26/1995CA2167311A1 Tri-substituted imidazoles having multiple therapeutic properties
01/26/1995CA2162040A1 Novel vitamin d analogues
01/25/1995EP0635491A1 (Thia) cycloalkyl(b)indoles, process of their preparation and compositions containing it
01/25/1995EP0635271A1 Therapeutic kits against proteinacious mediators, method of preparation and pharmaceutical compositions containing them
01/25/1995EP0635266A1 Composition comprising an omega 9 series unsaturated fatty acid in the treatment of medical symptions caused by leucotriene B4
01/25/1995EP0634934A1 Method of treatment of hiv-seropositive individuals with dietary whey proteins
01/25/1995EP0634930A1 Compounds useful for treating allergic and inflammatory diseases
01/25/1995EP0634927A1 Treatment and prophylaxis of diseases caused by parasites, or bacteria
01/25/1995EP0634896A1 Evaluation and treatment of patients with progressive immunosuppression
01/25/1995EP0576619B1 1,2-dithiole-3-thione derivative-based therapeutical compositions
01/25/1995EP0483216B1 Preparation of human adherent lymphokine-activated killer (a-lak) cells
01/25/1995CN1097758A Pyrrolopyrimidines
01/25/1995CN1097744A Urea derivative containing heterocyclic ring
01/25/1995CN1097727A Octahydrophenanthrene derivatives octahydrophenanthrenderivate
01/25/1995CN1097597A Cyclosporin soft capsule composition
01/24/1995US5384423 3-cycloalkyl-propanamides
01/24/1995US5384320 N-hydroxyurea derivatives which inhibit lipoxygenase
01/24/1995US5384319 Aminoalkylphenyl compounds
01/24/1995US5384316 4,16-diazatetracyclo[23.3.1.1.Hu 14,17=b . 0 Hu 4,9 triaconta-16,19-diene-2,3,10-trione derivatives
01/21/1995CA2128283A1 (thia)cycloalkyl¬b|indoles, their preparation process and pharmaceutical compositions containing them
01/20/1995CA2128151A1 Receptors of interleukin-12 and antibodies
01/19/1995WO1995002038A1 Yolk sac stem cells and their uses
01/19/1995WO1995001994A1 Recombinant ctla4 polypeptides and methods for making the same
01/19/1995WO1995001972A1 Heme binding compounds and use thereof
01/19/1995WO1995001802A1 Growth differentiation factor-7
01/19/1995CA2166694A1 Yolk sac stem cells and their uses
01/19/1995CA2166222A1 Heme binding compounds and use thereof
01/19/1995CA2165778A1 Growth differentiation factor-7
01/19/1995CA2144319A1 Recombinant ctla4 polypeptides and methods for making the same
01/18/1995EP0633931A1 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
01/18/1995EP0633929A1 METHOD FOR $i(IN VITRO) PROLIFERATION OF DENDRITIC CELL PRECURSORS AND THEIR USE TO PRODUCE IMMUNOGENS
01/18/1995EP0633881A1 Amine derivatives of oxo- and hydroxy-substitued hydrocarbons
01/18/1995EP0633783A1 Rapamycin formulation for iv injection
01/18/1995EP0633776A1 Compounds useful for treating allergic and inflammatory diseases
01/18/1995EP0633775A1 Compounds useful for treating inflammatory diseases and for inhibiting production of tumor necrosis factor
01/18/1995CN1097420A Sulfonate and carbamate derivatives of 3-aroylbenzo|B¨thiophenes
01/18/1995CN1097417A 新的杂环化合物 New heterocyclic compounds
01/17/1995US5382593 Antioxidants or anticoagulants
01/17/1995CA1334004C Essential fatty acid compositions
01/12/1995WO1995001350A1 Tetrazole derivatives having antihistaminic and antiallergic activity
01/12/1995WO1995001348A2 Imides as inhibitors of tnp alpha
01/12/1995WO1995001343A1 Pyridazinone derivatives with pharmaceutical activity
01/12/1995WO1995001338A1 Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors
01/12/1995WO1995001182A1 THF-η2 ANALOGS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
01/12/1995WO1995001175A1 Immunosuppressant and antiallergic compounds, e.g. n-(3-oxohexanoyl) homoserine lactone
01/12/1995CA2626178A1 Process for the preparation of thalidomide
01/12/1995CA2531868A1 Process for the preparation of thalidomide
01/12/1995CA2166289A1 Immunosuppressant and antiallergic compounds e.g. n-(3-oxohexanoyl) homoserine lactone
01/12/1995CA2165792A1 Tetrazole derivatives
01/11/1995EP0632808A1 Antiviral peptides
01/11/1995EP0632727A1 Conjugates formed from heat shock proteins and oligo- or polysaccharides
01/11/1995EP0544821B1 Indole derivatives as antiallergy and antiinflammatory agents
01/11/1995EP0362279B1 Saponin adjuvant
01/11/1995CN1097132A Zhenlongyin health-care wine
01/11/1995CN1027371C Synthetizing method for inner ester diterpenoid
01/10/1995US5380879 Immunosuppressants
01/10/1995US5380731 Piperidinyl benzimidazoles as antagonist of histamine H1
01/10/1995US5380726 Interleukin inhibitors
01/10/1995US5380724 Piperazine and homopiperazine derivatives, pharmaceutical compositions containing them and process for preparing same
01/10/1995CA1333906C Cycloalkylthiazole derivatives
01/10/1995CA1333852C Moulding contact lenses
01/05/1995WO1995000850A1 A novel family of pollen proteinases, methods of use thereof and compositions derived therefrom
01/05/1995WO1995000643A2 Human cell adhesion protein aamp-1 and uses thereof
01/05/1995WO1995000543A1 Anti-inflammatory peptides
01/05/1995WO1995000514A1 Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
01/05/1995WO1995000507A1 Azolyl-cyclic amine derivatives with immunomodulatory activity
01/05/1995WO1995000493A1 Imidazole derivatives as therapeutic agents
01/05/1995WO1995000482A1 Piperidine derivatives and process for their production
01/05/1995WO1995000480A1 Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
01/05/1995WO1995000163A1 Methods of isolating cd1-presented antigens, vaccines comprising cd1-presented antigens, and cell lines for use in said methods
01/05/1995WO1995000136A1 Method for treating hyperkeratosis and diseases mediated by proteases